Prelude Therapeutics (PRLD) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

PRLD is expected to report earnings to rise 13.02% to -48 cents per share on March 12

Prelude Therapeutics PRLD Stock Earnings Reports

Q4'24

Est.

$-0.49

Q3'24

Beat

by $0.04

Q2'24

Missed

by $0.04

Q1'24

Beat

by $0.07

Q4'23

Beat

by $0.04

The last earnings report on November 07 showed earnings per share of -43 cents, beating the estimate of -46 cents. With 426.13K shares outstanding, the current market capitalization sits at 57.24M.

View a ticker or compare two or three

Compare

PRLD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For PRLD
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

175 Innovation Boulevard

Phone

+1 302 467-1280

Employees

128

Web

https://www.preludetx.com